Work

EglN2 associates with the NRF1‐PGC1α complex and controls mitochondrial function in breast cancer

Year: 2015

Type: article

Source: The EMBO Journal

DOI: 10.15252/embj.201591437

Authors: Jing Zhang, Chengyang Wang, Xi Chen, Mamoru Takada, Cheng Fan, Xingnan Zheng, Haitao Wen, Yong Liu, Chenguang Wang, Richard G Pestell, Katherine M Aird, William G Kaelin, Xiaole Shirley Liu, Qing Zhang

Institutions: University of North Carolina at Chapel Hill, UNC Lineberger Comprehensive Cancer Center, Tongji University, Chinese Academy of Medical Sciences & Peking Union Medical College, Baylor College of Medicine, Thomas Jefferson University, Sidney Kimmel Cancer Center, The Wistar Institute, Howard Hughes Medical Institute, Harvard University, Dana-Farber Cancer Institute, Dana-Farber/Harvard Cancer Center

Language: English

Topic: Cancer, Hypoxia, and Metabolism

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

Funders: Howard Hughes Medical Institute, V Foundation for Cancer Research, University of North Carolina, National Institutes of Health, University of North Carolina at Chapel Hill, National Cancer Institute, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill

Awards: Role of the EglN2 Target FOXO3a in Breast Cancer, G1569999668, G2766465774, G5042472818, G5564678216, G5666405039, G738160294, G7667060700, G9000271451, Translational Research in Cancer

OpenAlex ID: W2123658031

FWCI: 1.57

Cites: 70

Cited by: 72

Related to: 10